Neurotrophic Keratopathy after wide retinal endolaser and postoperative Ketorolac eye drops : A case series
PURPOSE: We report a series of 5 cases, happened in a period of 5 months, who developed neurotrophic keratopathy (NK) following pars plana vitrectomy (PPV) and retinal endolaser for rhegmatogenous retinal detachment (RRD). In our several decennary experience of surgical center predominantly based on vitreoretinal surgery, we had rare cases of postoperative NK. These recent cases of post-surgical NK happened contextually to our change of postoperative non-steroidal anti-inflammatory drugs (NSAIDs) drops, based on Ketorolac Tromethamine 0.5% eye drops.
CASES PRESENTATION: Five patients with a mean age of 61 ± 7.3 years were treated with one or more PPV with intraoperative peripheral endolaser for RRD. Nobody had previous herpetic keratitis, systemic disease like diabetes mellitus or other predisposing factors for NK. In the postoperative period, all patients received Ketorolac Tromethamine 0.5% eye drops for a mean period of 54 ± 25 days. During follow-up visits they developed NK and they were successfully treated with suspension of Ketorolac eye drops, application of therapeutic contact lens or amniotic membrane patch and topical lubricant therapy.
CONCLUSIONS: Postoperative Ketorolac eye drops, in patients who underwent PPV with endolaser, may reduce the corneal sensitivity, predispose to epithelial disruption and NK development. Studies are needed to explore the effect of NSAIDs on corneal sensitivity reduction in patient who will undergo PPV and extensive endolaser.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
|---|---|
| Enthalten in: |
European journal of ophthalmology - (2024) vom: 22. Jan., Seite 11206721241228005 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Fossati, Giovanni [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Revised 23.01.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1177/11206721241228005 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367447347 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367447347 | ||
| 003 | DE-627 | ||
| 005 | 20240123232131.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240123s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1177/11206721241228005 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1268.xml |
| 035 | |a (DE-627)NLM367447347 | ||
| 035 | |a (NLM)38254249 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Fossati, Giovanni |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Neurotrophic Keratopathy after wide retinal endolaser and postoperative Ketorolac eye drops |b A case series |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 23.01.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a PURPOSE: We report a series of 5 cases, happened in a period of 5 months, who developed neurotrophic keratopathy (NK) following pars plana vitrectomy (PPV) and retinal endolaser for rhegmatogenous retinal detachment (RRD). In our several decennary experience of surgical center predominantly based on vitreoretinal surgery, we had rare cases of postoperative NK. These recent cases of post-surgical NK happened contextually to our change of postoperative non-steroidal anti-inflammatory drugs (NSAIDs) drops, based on Ketorolac Tromethamine 0.5% eye drops | ||
| 520 | |a CASES PRESENTATION: Five patients with a mean age of 61 ± 7.3 years were treated with one or more PPV with intraoperative peripheral endolaser for RRD. Nobody had previous herpetic keratitis, systemic disease like diabetes mellitus or other predisposing factors for NK. In the postoperative period, all patients received Ketorolac Tromethamine 0.5% eye drops for a mean period of 54 ± 25 days. During follow-up visits they developed NK and they were successfully treated with suspension of Ketorolac eye drops, application of therapeutic contact lens or amniotic membrane patch and topical lubricant therapy | ||
| 520 | |a CONCLUSIONS: Postoperative Ketorolac eye drops, in patients who underwent PPV with endolaser, may reduce the corneal sensitivity, predispose to epithelial disruption and NK development. Studies are needed to explore the effect of NSAIDs on corneal sensitivity reduction in patient who will undergo PPV and extensive endolaser | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Corneal wound healing | |
| 650 | 4 | |a cornea / external disease | |
| 650 | 4 | |a cornea/external disease | |
| 650 | 4 | |a diseases of the ocular surface | |
| 650 | 4 | |a diseases of the ocular surface: persistent corneal epithelial defects | |
| 650 | 4 | |a pars plana vitrectomy | |
| 650 | 4 | |a refractive surgery | |
| 650 | 4 | |a retina | |
| 650 | 4 | |a retinal detachment | |
| 650 | 4 | |a vitreous / endophthalmitis | |
| 700 | 1 | |a Bartoli, Elena |e verfasserin |4 aut | |
| 700 | 1 | |a Montericcio, Alessio |e verfasserin |4 aut | |
| 700 | 1 | |a Buzzi, Matilde |e verfasserin |4 aut | |
| 700 | 1 | |a Barone, Gianmaria |e verfasserin |4 aut | |
| 700 | 1 | |a Santoru, Francesco |e verfasserin |4 aut | |
| 700 | 1 | |a Allegrini, Davide |e verfasserin |4 aut | |
| 700 | 1 | |a Romano, Mario R |e verfasserin |4 aut | |
| 700 | 1 | |a Panico, Claudio |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of ophthalmology |d 1996 |g (2024) vom: 22. Jan., Seite 11206721241228005 |w (DE-627)NLM012606944 |x 1724-6016 |7 nnns |
| 773 | 1 | 8 | |g year:2024 |g day:22 |g month:01 |g pages:11206721241228005 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1177/11206721241228005 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 22 |c 01 |h 11206721241228005 | ||